Discipline test, not alpha test: maintain position and collect dividend while awaiting technical resolution
Maintain the position, reinvest the dividend, and wait for technical resolution on either side of $60.67-$65.00 before adjusting. The structural floor is intact and the dividend provides real carry, but volume distribution weakness, cocoa headwinds, and prior alpha lessons argue against fresh capital deployment. The trader's Hold with specified triggers is the correct execution.
| Position | Action |
|---|---|
| At $62.04 | No new adds |
| Overweight position | Trim to neutral over 2-4 weeks |
| Benchmark or below weight | Maintain current weight |
MDLZ is a defensive compounder with a coiled technical setup, multi-year Oreo relaunch catalyst, attractive valuation (PEG 0.92, forward P/E 18.45x), and macro tailwinds favoring defensives, making it positioned to break out from its $58-$66 range.
| Indicator | Value | Signal |
|---|---|---|
| Close | 62.04 | neutral |
| 10 EMA | 62.22 | bearish |
| 50 SMA | 61.92 | bullish |
| 200 SMA | 58.73 | bullish |
| MACD | -0.032 | bearish |
| MACD Histogram | -0.057 | neutral |
| RSI (14) | 48.09 | neutral |
| Bollinger Lower Band | 60.67 | bullish |
| Bollinger Mid (20 SMA) | 62.54 | neutral |
| Bollinger Upper Band | 64.41 | bearish |
| ATR | 1.24 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Gross margin expansion of 100bps+ Y/Y (cocoa cost normalization)
Then: Upgrade to Overweight
EV: $68-$70 (12-month target from entry at $62.04)
MDLZ's "coiled spring" technical setup is more likely to spring down than up; the stock faces unresolved cocoa margin pressure, deteriorating working capital, bearish technical signals, an overvalued multiple for sub-3% growth, and structural category headwinds from GLP-1 drugs and health trends.
EV: -$8 to -$6 (from $62.04 to $54-56 bear-case target at 15x forward EPS of $3.36) · concedes: MDLZ offers a dividend yield that provides income while waiting; Defensive CPG rotation can support the stock in risk-off environments; A confirmed breakout above $65 on volume >10M would invalidate the bear thesis
→ vs conservative: Volume distribution pattern showing 20.2M shares in July versus 7-8M on subsequent attempts is being misread as institutional selling—it's actually accumulation establishing a floor, with declining volume on resistance tests showing seller exhaustion, not supply overwhelming demand
→ vs conservative: Cocoa cost headwinds are already being offset by productivity gains as evidenced by Q2 gross margin expansion—waiting for full cocoa normalization means missing the entire re-rating that happens on the improvement trajectory
→ vs conservative: Three failed tests at $64.99 represent resistance ceiling weakening through absorption, not supply being unloaded—each failed test takes less volume to approach the level, classic Wyckoff re-accumulation
→ vs conservative: Conservative view treats this as binary directional bet when the actual asymmetric play is collecting 3.34 percent yield while optionality builds in background—the dividend effectively erodes cost basis while waiting
→ vs neutral: Stable rate environment is being treated as neutral when 95 percent probability of no Fed cuts makes defensive yield plays like MDLZ retain relative attractiveness versus bonds and risk assets at current levels
→ vs neutral: Macro setup is not neutral—0.40 beta with 3.34 percent yield is a rare combination in a 4+ percent 10-year environment where you're getting paid to wait with bond-like behavior but equity upside optionality
→ vs neutral: Catalyst calendar (General Mills September 23rd, Oreo 2027 relaunch) is being dramatically underestimated—management explicitly signaling multi-year brand investment on $5 billion franchise is not 'hope' but confirmed pipeline
→ vs neutral: Compressed volatility at 0.40 beta in constructive macro backdrop almost always produces directional breakout—'coin flip' characterization misses the asymmetric statistical edge of the setup
| neutral |
| Volume | 7.7M | neutral |
Support: 61.92 · 60.67 · 60.65 · 58.73 | Resistance: 62.22 · 62.45 · 64.41 · 64.7 · 64.99
MDLZ is in a textbook post-rally consolidation within an intact long-term uptrend. The combination of bullish 10/50/200 SMA stacking, price holding above the 50 SMA, MACD histogram narrowing toward zero, RSI at neutral 48, and Bollinger band squeeze with contracting ATR suggests the path of least resistance is eventually upward, but short-term tape is directionless. Existing long holders should hold with stop at ~$60.20 (1.5x ATR) or $60.67 (Bollinger lower band); new entrants should wait for confirmation via pullback to the 50 SMA/lower band zone or breakout above $64.70 with volume > 8M.
Market Cap
$79.18B
52-Week High
$66.65
52-Week Low
$51.20
Current Price
~$62.04 (≈62.0–62.1)
50-Day Moving Average
$61.87
200-Day Moving Average
$59.31
Beta
0.402
P/E (TTM)
22.73x
Forward P/E
18.45x
PEG Ratio
0.92
Price/Book
2.98x
Dividend Yield
3.34%
Gross Margin
~31.2%
Operating Margin (TTM)
21.98%
Profit Margin (TTM)
8.86%
Return on Equity (ROE)
13.34%
Return on Assets (ROA)
4.12%
EBITDA
$6.08B
Total Assets
$71.12B
Total Liabilities
$45.32B
Total Equity
$25.75B
Total Debt
$21.62B
Cash & Equivalents
$1.52B
Net Debt
$19.50B
Long-Term Debt
$15.47B
Current Debt
$5.56B
Working Capital
-$10.76B
Current Ratio
0.60
Debt/Equity
82.6
Goodwill + Intangibles
$43.8B
Treasury Stock
$31.4B
TTM Revenue
~$39.67B
TTM Net Income
~$3.52B
TTM EPS
$2.73
Forward EPS Estimate
$3.36
TTM Free Cash Flow
~$2.25B
Annual Capex
~$1.2–1.3B
Annual Dividends
~$2.5B
Interest Expense
~$1.5B/yr
Q1'26 Revenue
$10.50B
Q1'26 Gross Profit
$2.96B
Q1'26 Operating Income
$979M
Q1'26 Net Income
$669M
Q1'26 Diluted EPS
$0.52
Q1'26 EBITDA
$1.43B
Q1'26 Free Cash Flow
$155M
Q1'26 Capital Expenditures
-$312M
Q1'26 Dividends Paid
-$644M
Q4'25 Revenue
$9.74B
Q4'25 Net Income
$743M
Q4'25 Operating Cash Flow
$2.40B
Q4'25 Free Cash Flow
$1.999B
Q4'25 Buybacks
$492M
Q2'25 Net Income
$402M
Q2'25 Free Cash Flow
$3M
Cost of Revenue (YoY)
+3.6%
Q2'25 FX/Other Non-Operating Expense
~$520M
Strengths
Concerns
MDLZ is a high-quality defensive compounder trading at a fair valuation (Forward P/E 18.45x, PEG 0.92) with an attractive 3.34% dividend yield, supported by ~$2.25B in TTM free cash flow and an operating margin of 21.98%. The company carries significant leverage ($19.50B net debt) and faces margin pressure from cocoa/input cost inflation and multi-currency FX headwinds, but benefits from premium brand pricing power (Oreo, Cadbury), emerging-market growth exposure, and aggressive capital returns (>100% of FCF to shareholders). Best suited as a core defensive holding for income-oriented, risk-averse investors seeking yield and stability rather than aggressive growth.
Macro: Prediction markets price a 95% probability of no Fed rate cuts in 2026 (supporting defensive yield plays), only 10% US recession odds by YE 2026 (soft-landing base case), and 20% odds of CPI breaching 4.5% in 2026 (up 7pp/wk—rising tail risk to watch). UK recession odds stand at 10%. The macro setup favors defensive staples; the rising inflation probability is the key early-warning flag for input cost pressure.